Cargando…

Predictive immunohistochemical features for tumour response to chemoradiotherapy in rectal cancer

BACKGROUND: Reduced expression of cluster of differentiation (CD) 133 and cyclo‐oxygenase (COX) 2, and increased density of CD8+ tumour‐infiltrating lymphocytes, are associated with a favourable tumour response to preoperative chemoradiotherapy (CRT). This study aimed to evaluate these markers in re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinto, E., Omata, J., Sikina, A., Sekizawa, A., Kajiwara, Y., Hayashi, K., Hashiguchi, Y., Hase, K., Ueno, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093790/ https://www.ncbi.nlm.nih.gov/pubmed/32026629 http://dx.doi.org/10.1002/bjs5.50251

Ejemplares similares

Prognostic and predictive values of tumour budding in stage IV colorectal cancer
por: Nagata, K., et al.
Publicado: (2020)

Prognostic impact of histological categorisation of epithelial–mesenchymal transition in colorectal cancer
por: Ueno, H, et al.
Publicado: (2014)

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
por: McCoy, Melanie J., et al.
Publicado: (2017)

Sialyl Lewis(x) expression at the invasive front as a predictive marker of liver recurrence in stage II colorectal cancer
por: Yamadera, Masato, et al.
Publicado: (2018)

Magnetization transfer imaging to assess tumour response after chemoradiotherapy in rectal cancer
por: Martens, Milou H, et al.
Publicado: (2015)

Chemoradiotherapy response in recurrent rectal cancer
por: Yu, Stanley K T, et al.
Publicado: (2014)

Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
por: Hongo, Kumiko, et al.
Publicado: (2012)

Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancer
por: Pham, Trang Thanh, et al.
Publicado: (2021)

Small intestinal Crohn’s disease with hepatic portal venous gas: a case report
por: Yamadera, Masato, et al.
Publicado: (2016)

Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features
por: Zhang, Fang, et al.
Publicado: (2020)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
por: Balermpas, P, et al.
Publicado: (2014)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
por: Balermpas, P, et al.
Publicado: (2014)

The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
por: Liang, Yanting, et al.
Publicado: (2021)

Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients
por: Gim, Jungsoo, et al.
Publicado: (2016)

Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer
por: Filitto, Giuseppe, et al.
Publicado: (2022)

Clinical and radiomics prediction of complete response in rectal cancer pre-chemoradiotherapy
por: Mbanu, Peter, et al.
Publicado: (2022)

Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer
por: Cooke, S L, et al.
Publicado: (2011)

Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets
por: Tada, Noriko, et al.
Publicado: (2015)

MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer
por: Meng, Yankai, et al.
Publicado: (2017)

Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma
por: Ourô, Susana, et al.
Publicado: (2020)

Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy
por: Guo, Su-ping, et al.
Publicado: (2021)

Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
por: Zhang, Qi, et al.
Publicado: (2021)

Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models
por: Li, Moying, et al.
Publicado: (2022)

Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer
por: Benitez, Jose Carlos, et al.
Publicado: (2021)

Serum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
por: Hiyoshi, Yukiharu, et al.
Publicado: (2017)

Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden
por: Stockton, Joanne D., et al.
Publicado: (2021)

Proposal of a modified subclassification system for stage III colorectal cancer: A multi‐institutional retrospective analysis
por: Shinto, Eiji, et al.
Publicado: (2020)

Mucinous components assessed by magnetic resonance imaging in primary rectal cancer tissue before and after chemoradiotherapy and tumor response
por: Miyakita, Hiroshi, et al.
Publicado: (2018)

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
por: Martinez-Useros, J., et al.
Publicado: (2018)

Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Hanyang, et al.
Publicado: (2022)

Hepatic portal venous gas related to appendicitis
por: Kouzu, Keita, et al.
Publicado: (2018)

Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study
por: Hongo, Kumiko, et al.
Publicado: (2015)

Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer
por: Choi, Chi Hwan, et al.
Publicado: (2012)

Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
por: Zeng, Wei-Gen, et al.
Publicado: (2015)

MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer
por: Du, Binbin, et al.
Publicado: (2018)

Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer
por: Huang, Yan, et al.
Publicado: (2019)

Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer
por: Machackova, Tana, et al.
Publicado: (2019)

Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy
por: Yuan, Zhigang, et al.
Publicado: (2021)

Immunohistochemical identification of type I procollagen in tumour cells of scirrhous adenocarcinoma of the stomach.
por: Niitsu, Y., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_0apcnj8je2cnslbk4mjtfvb4si